FIELD: medicine, in particular immunogenic composition.
SUBSTANCE: claimed composition contains antigens of A and B influenza viruses, sorbed on Bifidobacterium bifidum bacterial cultures, immobilized on acceptable sorbent.
EFFECT: increased immunogenicity.
2 cl, 2 ex, 5 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| INFLUENZA VACCINE AND METHOD FOR PREPARING IT | 2010 |
|
RU2446824C2 |
| MUCOSAL INFLUENZA VIRUS VACCINE AND METHOD FOR INFLUENZA PREVENTION | 2004 |
|
RU2390351C2 |
| FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPs) | 2006 |
|
RU2483751C2 |
| METHOD FOR OBTAINING A TETRAVALENT VACCINE FOR THE PREVENTION OF INFLUENZA | 2020 |
|
RU2754398C1 |
| IMMUNOGENIC COMPOSITIONS AND METHODS | 2008 |
|
RU2468034C2 |
| VACCINE COMPOSITION FOR NON-IMMUNISED INDIVIDUALS | 2013 |
|
RU2661407C2 |
| EFFECTIVE INFLUENZA VLPS | 2004 |
|
RU2369405C2 |
| POLYVALENT VACCINE AGAINST INFLUENZA BASED ON NANOPARTICLES | 2019 |
|
RU2805552C2 |
| FUNCTIONALLY RECONSTRUCTED ADJUVANT-CONTAINING VIRUS MEMBRANES | 2004 |
|
RU2348428C2 |
| DNA STRUCTURE (VARIANTS), DNA-VECTOR, IMMUNOGENIC COMPOSITION AGAINST INFLUENZA VIRUS, METHOD OF IMMUNE RESPONSE INDUCTION, VACCINE AND METHOD OF VACCINATION | 1994 |
|
RU2193065C2 |
